RCTs, Registries & Surgeon Claims: How to Read Clinical Evidence

Every treatment comparison eventually hits a claim: "95% success rate." "Studies show." "In my hands, patients do great." The difference between patients who choose well and patients who get sold isn't medical training — it's a working sense of which claims deserve how much weight. This is that sense, compressed: how to read the evidence behind any procedure comparison, in an hour, without a statistics degree.

The pyramid, and why it's shaped that way

The ordering isn't academic snobbery; each tier removes a specific way of being fooled. Randomization removes the biggest one: without it, patients who get treatment A differ systematically from patients who get B (healthier, richer, earlier-stage), and the outcome difference you observe may be the patients, not the treatments. Systematic reviews remove the second: any single trial can be an outlier, and pooling all trials — including unflattering ones — shows whether a result survives replication. Registries and cohorts add real-world scale at the price of reintroducing the who-gets-what problem. Case series and testimonials sit at the bottom because they can't show what happened to comparable patients who chose differently — which is the entire question a comparison asks.

Reading a claimed success rate: the five interrogations

• Success at what, exactly? "Success" might mean the vein closed, the implant survived, the pain improved 20%, or the patient said they were satisfied. These are wildly different bars. Ask for the definition before the number means anything.
• Measured when? One-year success rates flatter almost everything; the honest comparisons live at 5–10 years, where redo rates, regain, and late complications surface. A treatment that wins at year one and loses at year seven is a common pattern.
• In whom? Trial populations are curated — often younger, healthier, and earlier-stage than you. The calibrating question for any provider: "in patients matching my picture, not the study's, what do you see?"
• Compared to what? A 90% success rate is meaningless without the alternative's number — and without the do-nothing arm. Some conditions improve substantially untreated, which quietly inflates every treatment's apparent success.
• Counted by whom? Industry-funded studies aren't automatically wrong, but funding predicts favorable framing reliably enough that checking the disclosure section is part of reading the paper. Same for a surgeon quoting personal statistics: ask whether complications and lost-to-follow-up patients are in the denominator.

Registries: the underrated middle tier

For surgical comparisons especially, national and specialty registries — joint replacement registries are the exemplar — quietly outperform both marketing and single studies for one question patients care about most: durability. Registries track redo rates on entire populations across decades, which is how the field learned which implants and techniques actually last. When comparing device-dependent or technique-dependent procedures, asking "what do the registries show for this approach at ten years?" is a professional-grade question that takes one sentence.

The one-hour patient evidence workflow

• Minutes 0–15: find the relevant specialty-society guideline for your condition (they're free, written to summarize the pyramid's top, and updated on cycles). Read the recommendations section and note the strength-of-evidence grades attached to each option.
• Minutes 15–35: search PubMed for a recent systematic review or meta-analysis comparing your specific options; read the abstract and conclusions. One good review outweighs fifty articles about studies.
• Minutes 35–45: check for registry data if your comparison involves implants or durability.
• Minutes 45–60: write the question list — every claim you couldn't verify becomes a question for the providers, phrased as: "the guideline/review says X; your recommendation differs — help me understand why my case is the exception." That sentence, politely delivered, is the single most clarifying instrument in medical consumerism: good doctors answer it well, and the answer's quality is itself the data.

Reading the gaps: what the evidence doesn't say

Evidence literacy's advanced skill is noticing absences. Many comparisons that matter to patients have never been run head-to-head — new devices get approved against predicates rather than against the incumbent therapy in long trials; surgical techniques evolve faster than ten-year data can accumulate; and "no evidence of difference" frequently means "nobody funded that comparison," not "proven equivalent." Three flavors of gap to name at consults. The follow-up gap: a technique introduced four years ago cannot have seven-year data, whatever its marketing implies — ask what the longest published follow-up actually is. The population gap: if the trials enrolled patients unlike you (younger, thinner, earlier-stage), the honest framing is extrapolation, and your provider should say so unprompted. The comparator gap: studies comparing a treatment against placebo or "usual care" answer a different question than studies comparing it against the best alternative — and options tested only against weak comparators wear inflated win rates. None of these gaps means refusing new options; newer techniques are often genuinely better. It means pricing uncertainty honestly: an option with shorter evidence deserves either a discount in your weighting or a compensating advantage (recovery, reversibility) that justifies accepting the unknown — and a provider who volunteers the gaps is exhibiting exactly the epistemic honesty you want holding the scalpel.

This article compares treatment options in general terms for educational purposes. It is not medical advice, and no comparison framework replaces an examination, imaging, and a conversation with a licensed physician who knows your case — candidacy, risks, and outcomes are individual. Any pricing reflects typical 2026 ranges, not quotes. ProcedureCompare.co is part of the ColombiaMedical.co network and may receive referral fees from providers; this never changes the prices you pay.